Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy

Journal of Neurology

Volumn 262, Issue 3, 2015, Pages 771-773

  Lehmann, Helmar C ^a   Krüger, Klaus ^b   Fink, Gereon R ^a,c   Schroeter, Michael ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b Neurology Practice   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; FILGRASTIM; IMMUNOGLOBULIN; MEFLOQUINE; MIRTAZAPINE; OLIGOCLONAL BAND; IMMUNOLOGICAL ADJUVANT;

ADULT; ATAXIC GAIT; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBELLUM INJURY; CEREBROSPINAL FLUID; DEMYELINATING DISEASE; DRUG WITHDRAWAL; FEMALE; FRONTAL LOBE; HEMIPARESIS; HUMAN; IMMUNOGLOBULIN DEFICIENCY; IMMUNOMODULATION; JC VIRUS; LETTER; LYMPHOCYTOPENIA; MIDDLE AGED; MONOTHERAPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RIGHT HEMISPHERE; SPASTIC PARESIS; CHEMICALLY INDUCED; COMPLICATION; DYSARTHRIA; GAIT ATAXIA; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;

ADJUVANTS, IMMUNOLOGIC; DYSARTHRIA; FEMALE; GAIT ATAXIA; HUMANS; INTERFERON BETA-1A; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 84925535538     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7620-4     Document Type: Letter

References (11)

1. Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48
2. Happe S, Husstedt IW (2000) Successful treatment of acute encephalomyelitis associated with common variable immunodeficiency syndrome (CVID): case report and review of the literature. J Neurol 247:562–565
3. Narula S, LaRosa DF, Kamoun M, Dalmau J, Levinson AI (2007) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol 98:483–489
4. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS (2008) Common variable immunodeficiency: a new look at an old disease. Lancet 372:489–502
5. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302
6. Rieckmann P, Heidenreich F, Sailer M, Zettl UK, Zessack N, Hartung HP, Gold R (2012) Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis. Ther Adv Neurol Disord 5:3–12
7. Rudge P, Webster AD, Revesz T, Warner T, Espanol T, Cunningham-Rundles C, Hyman N (1996) Encephalomyelitis in primary hypogammaglobulinemia. Brain 119(Pt 1):1–15
8. Scotton PG, Vaglia A, Carniato A, Marchiori GC (1998) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency. Clin Infect Dis 26:215–216
9. Snyder MD, Storch GA, Clifford DB (2005) Atypical PML leading to a diagnosis of common variable immunodeficiency. Neurology 64:1661
10. Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F (2013) The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler 19:1826–1840
11. Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075–1080